Strides Pharma Shares Soar 12% on Strong Q3 Results, Positive Outlook
Business
M
Moneycontrol•30-01-2026, 13:49
Strides Pharma Shares Soar 12% on Strong Q3 Results, Positive Outlook
- •Strides Pharma's shares jumped 12% after announcing robust December quarter results.
- •Net profit surged to ₹202 crore from ₹88 crore year-on-year, with revenue reaching ₹1,194.6 crore.
- •EBITDA increased by 12.2% to ₹235.8 crore, and margin improved by 150 basis points to 19.7%.
- •US sales were $70 million, and the company reiterated its $400 million US revenue outlook by FY28.
- •Growth Markets revenue rose 19% to $16.6 million, driven by the Africa business.
Why It Matters: Strides Pharma's strong Q3 performance and positive business outlook led to a significant 12% share price increase.
✦
More like this
Loading more articles...
